Johnson & Johnson announced that Phase 3 trials are complete for its COVID-19 vaccine and show the single-dose shot to be 85% effective overall at preventing hospitalization and death in all regions...
Our website uses cookies. Please review our privacy policy to find out more about the cookies we use. Browsing our website means you accept these terms.